Psychopharmacology Section, Division of Psychiatry, University of Nottingham, Nottingham, UK.
J Psychopharmacol. 2012 Jun;26(6):857-70. doi: 10.1177/0269881111408961. Epub 2011 Sep 2.
The atypical antipsychotic drug clozapine has multiple pharmacological actions, some of which, including 5-hydroxytryptamine (5-HT₂) and histamine (H₁) receptor antagonist effects, are shared by the non-selective 5-HT receptor antagonist cyproheptadine. Atypical antipsychotics have a characteristic profile of action on operant behaviour maintained by progressive ratio schedules, as revealed by Killeen's (1994) mathematical model of schedule controlled behaviour. These drugs increase the values of a parameter that expresses the 'incentive value' of the reinforcer (a) and a parameter that is inversely related to the 'motor capacity' of the organism (δ). This experiment examined the effects of acute treatment with cyproheptadine and clozapine on performance on a progressive ratio schedule of food reinforcement in rats; the effects of a conventional antipsychotic, haloperidol, and two drugs with food intake-enhancing effects, chlordiazepoxide and Δ⁹-tetrahydrocannabinol (THC), were also examined. Cyproheptadine (1, 5 mg kg⁻¹) and clozapine (3.75, 7.5 mg kg⁻¹) increased a and δ. Haloperidol (0.05, 0.1 mg kg⁻¹) reduced a and increased δ. Chlordiazepoxide (3, 10 mg kg⁻¹) increased a but reduced δ. THC (1, 3 mg kg⁻¹) had no effect. Interpretation based on Killeen's (1994) model suggests that cyproheptadine and clozapine enhanced the incentive value of the reinforcer and impaired motor performance. Motor impairment may be due to sedation (possibly reflecting H₁ receptor blockade). Enhancement of incentive value may reflect simultaneous blockade of H₁ and 5-HT₂ receptors, which has been proposed as the mechanism underlying the food intake-enhancing effect of cyproheptadine. In agreement with previous findings, haloperidol impaired motor performance and reduced the incentive value of the reinforcer. Chlordiazepoxide's effect on a is consistent with its food intake-enhancing effect.
非典型抗精神病药物氯氮平具有多种药理作用,其中一些作用,包括 5-羟色胺(5-HT₂)和组胺(H₁)受体拮抗剂作用,与非选择性 5-HT 受体拮抗剂赛庚啶共享。非典型抗精神病药对操作性行为有特征性的作用模式,这一点在 Killeen(1994 年)的操作性行为控制模型中得到了揭示。这些药物增加了一个参数的值,该参数表示强化物的“激励价值”(a)和一个与生物体“运动能力”成反比的参数(δ)。本实验研究了赛庚啶和氯氮平急性处理对大鼠食物强化递增比率方案表现的影响;还研究了一种传统的抗精神病药物氟哌啶醇以及两种具有增强食物摄入作用的药物,地西泮和Δ⁹-四氢大麻酚(THC)的作用。赛庚啶(1、5mg/kg)和氯氮平(3.75、7.5mg/kg)增加了 a 和 δ。氟哌啶醇(0.05、0.1mg/kg)降低了 a 值并增加了 δ 值。地西泮(3、10mg/kg)增加了 a 值但降低了 δ 值。THC(1、3mg/kg)没有影响。基于 Killeen(1994 年)模型的解释表明,赛庚啶和氯氮平增强了强化物的激励价值并损害了运动表现。运动障碍可能是由于镇静(可能反映 H₁ 受体阻断)。激励价值的增强可能反映了 H₁ 和 5-HT₂ 受体的同时阻断,这被认为是赛庚啶增强食物摄入作用的机制。与先前的发现一致,氟哌啶醇损害了运动表现并降低了强化物的激励价值。地西泮对 a 的影响与其增强食物摄入的作用一致。